enVVeno Medical (NVNO) Non Operating Investment Income (2022 - 2026)
enVVeno Medical (NVNO) recorded quarterly Non Operating Investment Income of -$43000.0 in Q1 2026, up 45.57% quarter-over-quarter from -$79000.0 in Q4 2025, and up 78.5% on a YoY basis from -$24089.6 in Q1 2025.
enVVeno Medical (NVNO) Non Operating Investment Income (2022 - 2026) Analysis & Trends
enVVeno Medical's Non Operating Investment Income history runs 5 years deep, the most recent figure standing at -$43000.0 for Q1 2026.
- In Q1 2026, Non Operating Investment Income rose 78.5% year-over-year to -$43000.0; the TTM figure through Mar 2026 stood at -$240000.0 (up 9.77% YoY), while the FY2025 annual figure was -$391000.0, down 1677.27% from the prior year.
- Non Operating Investment Income was -$43000.0 for Q1 2026 at enVVeno Medical, up from -$79000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $278000.0 in Q1 2023 to a low of -$200000.0 in Q1 2025.
- Historically, Non Operating Investment Income has averaged $733.33 across 5 years, with a median of -$39000.0 in 2025.
- The sharpest annual moves came in 2023 and 2025: Non Operating Investment Income soared 842.86% in 2023, then plunged 750.0% in 2025.
- A 5-year view of Non Operating Investment Income shows it stood at $183000.0 in 2022, then tumbled by 154.1% to -$99000.0 in 2023, then declined by 19.19% to -$118000.0 in 2024, then soared by 33.05% to -$79000.0 in 2025, then jumped by 45.57% to -$43000.0 in 2026.
- The last three Non Operating Investment Income figures came in at -$43000.0 (Q1 2026), -$79000.0 (Q4 2025), and -$39000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | enVVeno Medical | 6.64 Mn | 6.64 Mn | - | -43,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43,000.00 |
| Mar 31, 2026 | -43,000.00 |
| Dec 31, 2025 | -79,000.00 |
| Dec 31, 2025 | -79,000.00 |
| Sep 30, 2025 | -39,000.00 |
| Sep 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -79,000.00 |
| Jun 30, 2025 | -79,000.00 |
| Mar 31, 2025 | -200,000.00 |
| Mar 31, 2025 | -200,000.00 |
| Dec 31, 2024 | -118,000.00 |
| Dec 31, 2024 | -118,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Dec 31, 2023 | -99,000.00 |
| Dec 31, 2023 | -99,000.00 |
| Sep 30, 2023 | 156,000.00 |
| Sep 30, 2023 | 156,000.00 |